Ep Biocomposites Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 14, 2026

Key Highlights

The Latest Trading Price of EP Biocomposites Ltd is ₹ 99.1 as of 11 Mar 15:30 . The P/E Ratio of EP Biocomposites Ltd changed from 58.8 on March 2023 to 20.1 on March 2025 . This represents a CAGR of -30.08% over 3 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of EP Biocomposites Ltd changed from ₹ 33.88 crore on March 2023 to ₹ 20.75 crore on March 2025 . This represents a CAGR of -15.08% over 3 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of EP Biocomposites Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About EP Biocomposites Ltd

EP Biocomposites Limited was incorporated as Public Limited Company on January 17, 2020 with the Registrar of Companies, Goa.
Further, pursuant to Business Takeover Agreement dated August 31, 2021, the Company took over the running business of M/s.
OM Ventures, a proprietorship concern through one of its Promoter Leena Kamat.
In September 2022, Company made an Initial Public Offer of 5,04,000 Equity Shares of Rs 10 each by raising funds aggregating to Rs. 6.35 Crore. The Company is involved in manufacturing and supplying of a vast portfolio of products and services, which includes Fibre Glass doors and allied products, Bio Digester Toilets with DRDO technology and actively contributing to wastewater recycling through its solution in Sewage Treatment Plants (STP)and Effluent Treatment Plants (ETP).

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of EP Biocomposites Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, EP Biocomposites Ltd or Sheel Biotech Ltd?

Market cap of EP Biocomposites Ltd is 16 Cr while Market cap of Sheel Biotech Ltd is 111 Cr

What are the key factors driving the stock performance of EP Biocomposites Ltd and Sheel Biotech Ltd?

The stock performance of EP Biocomposites Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for EP Biocomposites Ltd and Sheel Biotech Ltd?

As of March 14, 2026, the EP Biocomposites Ltd stock price is INR ₹99.1. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.8.

How do dividend payouts of EP Biocomposites Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of EP Biocomposites Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.